GE Capital supplies $10M term loan facility to InfraReDx

GE Capital, Healthcare Financial Services has announced that it is the sole lender on a $10 million senior secured multidraw term loan to Burlington, MA-based InfraReDx. The financing will be used to help support commercialization efforts for its heart disease imaging system.

InfraReDx's TVC imaging system (pictured) is the only multimodality device to combine intravascular ultrasound and near-infrared spectroscopy. The system, which is FDA-cleared for the detection of lipid core plaques of interest, was recently profiled at the annual Transcatheter Cardiovascular Therapeutics Meeting in San Francisco.

"We've worked with GE Capital in the past so they are highly knowledgeable about our business and industry," said Donald Southard, InfraReDx's president and CEO. "This expertise was essential in structuring a financing solution commensurate with the company's immediate and longer term growth objectives."

- get more from the GE Capital release

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.